OceanBase Records Over 100% Increase in Number of Customers
13.1.2022 09:59:00 EET | Business Wire | Press release
OceanBase,an enterprise-level distributed relational database provider, announced during this year’s Distributed Database Developer Conference that its database products have been adopted by over 400 customers, which equals to a year-on-year increase of over 100% from 2020 to 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220112006074/en/
Yang Bing, CEO of OceanBase, speaking during the Distributed Database Developer Conference on January 6, 2022. (Photo: Business Wire)
OceanBase, an Ant Group company, has seen its business expanding rapidly during the past year. So far, a quarter of the top 200 financial institutions in China have chosen OceanBase as a preferred technology provider to upgrade their core IT systems. OceanBase is also serving customers from non-financial service industries such as energy, telecommunication, and transportation. Customers from these sectors contribute to about 35 percent of OceanBase's total revenue.
Meanwhile, OceanBase is exploring the Small and Medium Enterprises (SMEs) market, which now accounts for near 70 percent of its customer base. Regional banks, insurers, security brokers, and wealth management companies have also been partnering with OceanBase and see it as one of the leading database technology providers.
"With its 'product-driven growth' business model, OceanBase aims to make database system management and operation easier and more seamless, " said Yang Bing, CEO of OceanBase. "We look forward to working with partners, customers, developers, and other industry participants to accelerate the development of database technology with continuous technology and product innovations."
"The distributed database is able to handle computing tasks across different nodes, bringing great advantages to dealing with large throughput and group computing," said Michael “Monty” Widenius, founder at MariaDB Foundation and the main author of the original version of the open-source MySQL in the conference. As for open-sourced database products like MariaDB and OceanBase, he commented, “Products and communities will maintain their vitality when they attract tens of millions of users while building healthy businesses."
The rapid development of the internet industry is accelerating the technology innovations of distributed databases that naturally have the ability to expand on a large scale. According to a recent report released by market intelligence provider Gartner, with advanced features including high availability, high scalability, multimodal implementation, supports of hybrid workloads and high compatibility, native distributed databases such as OceanBase are leading the trend of development in database technology, and the CAGR of the global market reaches 16.9 percent.
This year’s Distributed Database Developer Conference was co-hosted by CSDN, Mulan Open-source Community, Open Source China, and OceanBase on January 6. Other speakers participating in the conference included Bruce Momjian, co-founder and core team member of the PostgreSQL Global Development Group, Li Haixiang, the chief architect of Tencent's distributed database TDSQL, and Liu Song, VP of PingCAP.
About OceanBase
Launched in 2010, OceanBase is an enterprise-level distributed relational database developed by Ant Group. OceanBase’s benefits over alternative solutions include strong data consistency, high availability, high performance, low cost, online scalability, and high compatibility with SQL standards and other mainstream relational databases. Its performance has been proven in many Alipay large-scale business scenarios, as well as at the annual 11.11 Global Shopping Festival. In May 2020, OceanBase set the world record for online transaction processing performance, with 707 million transactions per minute in a TPC-C benchmark test. OceanBase was officially registered as a separate company in June 2020.
To learn more, please visit: https://www.oceanbase.com/en
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220112006074/en/
Contact information
Media Inquires
Vick Li Wei
OceanBase
Vick.lw@antgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release
Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release
Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release
Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
